Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Clinical studies support the efficacy of programmed cell death 1 (PD-1) targeted therapy in a subset of patients with metastatic gastric cancer (mGC). With the goal of identifyi...